NSI 532 IGFAlternative Names: HK 532 IGF1; NSI-532-IGF; NSI-532.IGF
Latest Information Update: 15 Nov 2014
At a glance
- Originator Neuralstem
- Class Antidementias; Neuroprotectants; Stem cell therapies
- Mechanism of Action Cell replacements
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Preclinical Alzheimer's disease
Most Recent Events
- 01 Sep 2014 Preclinical trials in Alzheimer's disease in USA (Intracerebral)